| Article | Date | Source |
|---|
| EpiCept Corporation (EPCT) Reports Second Quarter 20 | -- | Biotechnology - Moreover |
| EpiCept Announced It Received Initial Written Response From The FDA (EPCT) | -- | Pharmaceutical - Moreover |
| EpiCept Reports First Quarter 2012 Operating and Financial Results | May 09, 2012 | FDA News - Business Wire |
| EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012 | May 04, 2012 | Pharma News - Business Wire |
| EpiCept Corporation's AmiKet??? Receives Fast Track Designation from FDA | April 10, 2012 | BioSpace |
| EpiCept to Raise $1.1 Million in Registered Direct Offering | March 29, 2012 | FDA News - Business Wire |
| EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results | February 29, 2012 | Pharma News - Business Wire |
| EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012 | February 23, 2012 | Pharma News - Business Wire |
| EpiCept to Raise $2 Million in Registered Direct Offering | February 09, 2012 | Pharma News - Business Wire |
| EpiCept to Present at the 14th Annual BIO CEO & Investor Conference | February 08, 2012 | Pharma News - Business Wire |
| EpiCept Corporation Files for AmiKet??? Fast Track Designation | February 07, 2012 | BioSpace - Breaking News |
| EpiCept Files for AmiKet™ Fast Track Designation | February 07, 2012 | FDA News - Business Wire |
| EpiCept Corporation Confirms Engagement of SunTrust Robinson Humphrey to Include Evaluation of Potential Sale Transactions | January 24, 2012 | FDA News - Business Wire |
| EpiCept Corporation Receives Finalized FDA Guidance for AmiKet??? Phase III CIPN Program and Regulatory Strategy | January 23, 2012 | BioSpace - Breaking News |
| Epicept upbeat on FDA guidance for Amiket Phase III programme | January 23, 2012 | Biotechnology - Moreover |
| EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory Strategy | January 23, 2012 | FDA News - Business Wire |
| EpiCept Corporation Reduces Exercise Price and Extends Expiration Date of June 2010 Series B Warrants | January 09, 2012 | Pharma News - Business Wire |
| EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ Potential | January 09, 2012 | Pharma News - Business Wire |
| EpiCept Corporation Appoints Alan W. Dunton, M.D. Non-Executive Chairman of the Board | January 05, 2012 | Pharma News - Business Wire |
| EpiCept Corporation Receives FDA Permission to Initiate AmiKet™ Phase III Clinical Development | December 23, 2011 | FDA News - Business Wire |
| EpiCept Corp. Joins OTCQX | September 19, 2011 | Pharma News - PR Newswire |
| EpiCept Corporation (EPCT) Common Stock to Begin Trading on OTCQX(R), The Highest Tier of the OTC Market, on September 19, 20 | September 16, 2011 | Biotechnology - Moreover |
| EpiCept Corporation Common Stock to Begin Trading on The Highest Tier of the OTC Market, on September 19, 2011 | September 16, 2011 | BioSpace - Breaking News |
| EpiCept Common Stock to Begin Trading on OTCQX®, The Highest Tier of the OTC Market, on September 19, 2011 | September 15, 2011 | Pharma News - Business Wire |
| EpiCept Corporation Provides U.S. Regulatory Update for Ceplene® Clinical Development | September 12, 2011 | FDA News - Business Wire |
| EpiCept Common Stock Approved for Primary Listing on OMX Stockholm Exchange | September 07, 2011 | FDA News - Business Wire |
| EpiCept Corporation Reports Second Quarter 2011 Financial Results and Provides Business Update | August 15, 2011 | Pharma News - Business Wire |
| EpiCept to Report Second Quarter 2011 Operating Highlights and Financial Results on August 15, 2011 | August 09, 2011 | Pharma News - Business Wire |
| EpiCept Corporation Announces Publication in Journal Blood of a New Meta-Analysis Examining Lack of Efficacy of Interleukin-2 as Monotherapy in AML Remission Maintenance | July 18, 2011 | Pharma News - Business Wire |
| EpiCept Corporation stockholders approve reverse stock split proposal | June 30, 2011 | Pharmaceutical - Moreover |
| EpiCept Corporation Announces Reconvened Stockholders’ Meeting Results | June 28, 2011 | Pharma News - Business Wire |
| EpiCept Corporation Receives Initial FDA Comments on Application for Ceplene(R) Special Protocol Assessment
| June 27, 2011 | BioSpace - Breaking News |
| EpiCept Receives Initial FDA Comments on Application for Ceplene® Special Protocol Assessment | June 27, 2011 | FDA News - Business Wire |
| EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange | June 22, 2011 | FDA News - Business Wire |
| EpiCept Corporation Announces Stockholders’ Meeting Results and Adjournment | June 20, 2011 | Pharma News - Business Wire |
| EpiCept Announces Resignation of Board Member | June 17, 2011 | Pharma News - Business Wire |
| EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16 | June 13, 2011 | Pharma News - Business Wire |
| EpiCept Receives Positive Nasdaq Panel Decision | June 07, 2011 | Pharma News - Business Wire |
| EpiCept Corporation Obtains New $10.6 Million Secured Debt Financing | May 31, 2011 | BioSpace - Breaking News |
| EpiCept Obtains New $10.6 Million Secured Debt Financing; Prepays Outstanding Convertible Notes | May 31, 2011 | FDA News - Business Wire |
| EpiCept to Present at the 18th Annual Euro-Biotech Forum | May 19, 2011 | Pharma News - Business Wire |
| EpiCept Corporation (EPCT) Reports First Quarter 20 | May 10, 2011 | Biotechnology - Moreover |
| EpiCept Corporation Files Protocol with FDA for Ceplene(R) Phase III Confirmatory Trial
| May 10, 2011 | BioSpace - Breaking News |
| EpiCept Corporation Reports First Quarter 2011 Financial Results and Provides Business Update | May 10, 2011 | Pharma News - Business Wire |
| EpiCept Files Protocol with FDA for Ceplene® Phase III Confirmatory Trial | May 09, 2011 | FDA News - Business Wire |
| EpiCept Corporation (EPCT) to Report First Quarter 2011 Operating and Financial Results on May 10, | May 06, 2011 | Biotechnology - Moreover |
| EpiCept to Report First Quarter 2011 Operating and Financial Results on May 10, 2011 | May 05, 2011 | Pharma News - Business Wire |
| EpiCept A Deep And Balanced Pipeline | April 16, 2011 | Pharmaceutical - Moreover |
| EpiCept Receives Nasdaq Staff Determination Letter | April 08, 2011 | Pharma News - Business Wire |
| EpiCept to Raise $4.6M to Meet Working Capital Needs | March 29, 2011 | Inside Industry - Gen |
| EpiCept to Raise $4.6 Million in Registered Direct Offering | March 29, 2011 | FDA News - Business Wire |
| EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic... | March 28, 2011 | Pharmaceutical - Moreover |
| EPICEPT: to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference | March 28, 2011 | Pharmaceutical - Moreover |
| EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference (BIZ) | March 28, 2011 | Pharmaceutical - Moreover |
| EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference | March 28, 2011 | Pharma News - Business Wire |
| EpiCept Corp: Initiating Coverage With Outperform Rating | March 22, 2011 | Pharmaceutical - Moreover |
| EpiCept to Present at the Cowen and Company 31st Annual Healthcare Conference | March 03, 2011 | Pharma News - Business Wire |
| EpiCept Identifies Subgroup of AML Patients Who Benefit Most from Ceplene Therapy | March 03, 2011 | Inside Industry - Gen |
| EpiCept Identifies Ceplene® Survival Benefit in Key AML Subgroup | March 03, 2011 | Pharma News - Business Wire |
| EpiCept Reports Fourth Quarter and Full Year 2010 Operating and Financial Results | February 24, 2011 | FDA News - Business Wire |
| EpiCept to Present at The Wall Street Analyst Forum 22nd Annual Investor Conference | February 23, 2011 | Pharma News - Business Wire |
| EpiCept to Report Fourth Quarter and Full Year 2010 Operating and Financial Results on February 24, 2011 | February 18, 2011 | Pharma News - Business Wire |
| EpiCept Corporation (EPCT) to Present at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference on February | February 18, 2011 | Biotechnology - Moreover |
| EpiCept to Present at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference on February 17 | February 16, 2011 | Pharma News - Business Wire |
| EpiCept Corporation (EPCT) to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference | February 11, 2011 | Biotechnology - Moreover |
| EpiCept to Present at the 13th Annual BIO CEO & Investor Conference | February 09, 2011 | Pharma News - Business Wire |
| EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy | February 07, 2011 | FDA News - Business Wire |
| EpiCept to Present at Two Upcoming Industry Conferences | January 06, 2011 | Pharma News - Business Wire |
| EpiCept Regains Compliance With Nasdaq’s Minimum Market Value of Listed Securities | January 03, 2011 | Pharma News - Business Wire |
| EpiCept Corporation Announces Initiation of Phase 2B Study of Azixa(TM) for Front-Line Treatment of Glioblastoma Multiforme by Myrexis | December 28, 2010 | BioSpace - Breaking News |
| EpiCept: Myrexis Testing Azixa Vs. Glioblastoma | December 28, 2010 | Health News - Fox Business |
| EpiCept Announces Initiation of Phase 2B Study of Azixa™ for Front-Line Treatment of Glioblastoma Multiforme by Myrexis | December 28, 2010 | FDA News - Business Wire |
| EpiCept leukemia drug approved in Israel | December 21, 2010 | Health News - CNBC |
| EpiCept Announces Ceplene® Approved for Marketing in Israel | December 21, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Announces Initiation by National Cancer Institute of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer | December 15, 2010 | BioSpace - Breaking News |
| EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin™ in Anaplastic Thyroid Cancer | December 15, 2010 | FDA News - Business Wire |
| EpiCept climbs on results from Ceplene analysis | December 10, 2010 | Health News - CNBC |
| EpiCept Corporation Reports New Analysis Supports Ceplene's Favorable Impact on Overall Survival | December 10, 2010 | BioSpace - Breaking News |
| EpiCept Reports New Analysis Supports Ceplene’s Favorable Impact on Overall Survival | December 10, 2010 | FDA News - Business Wire |
| EpiCept Announces Ceplene® Poster Presentation at the 52nd Annual Meeting of the American Society of Hematology | December 06, 2010 | FDA News - Business Wire |
| EpiCept Corp to give presentation at NYSSA Biotech and Specialty Pharmaceuticals Conference | November 26, 2010 | Pharmaceutical - Moreover |
| EpiCept Corporation to Present at the NYSSA Biotech and Specialty Pharmaceuticals Conference | November 26, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Reports Third Quarter 2010 Operating and Financial Results | November 09, 2010 | Pharma News - Business Wire |
| Rodman & Renshaw Acts as Exclusive Placement Agent to EpiCept Corporation on $2 Million Registered Direct Offering | November 08, 2010 | Pharma News - Business Wire |
| EpiCept to Secure Almost $2M via Registered Direct Financing | November 08, 2010 | Inside Industry - Gen |
| EpiCept Raises $2 Million via Registered Direct Financing | November 08, 2010 | Pharma News - Business Wire |
| EpiCept Provides Update on Its 2011 Financing Plan | November 05, 2010 | Pharma News - Business Wire |
| EpiCept to Report Third Quarter 2010 Operating and Financial Results on November 9, 2010 | November 04, 2010 | Pharma News - Business Wire |
| EpiCept Corporation and FDA Agree on Development Plan for Ceplene® | October 28, 2010 | FDA News - Business Wire |
| EpiCept Receives Nasdaq Listing Notices | October 08, 2010 | FDA News - Business Wire |
| EpiCept Corporation (EPCT) to Present at the 9th Annual Biotechnology Industry Organization (BIO) Investor Forum | September 30, 2010 | Biotechnology - Moreover |
| EpiCept Corporation to Present at the 9th Annual BIO Investor Forum | September 29, 2010 | FDA News - Business Wire |
| EpiCept Corporation to Present at the Rodman & Renshaw 12th Annual Global Investment Conference | September 08, 2010 | Pharma News - Business Wire |
| EpiCept Sinks On FDA Rejection | August 23, 2010 | Health News - Fox Business |
| EpiCept shares hammered after FDA rejects app, demands new trial | August 23, 2010 | FierceBiotech |
| EpiCept Corporation Receives Refusal to File Letter from US FDA on Ceplene New Drug Application | August 23, 2010 | FDA News - Business Wire |
| EpiCept Corporation Reports Second Quarter 2010 Operating and Financial Results | August 06, 2010 | Pharma News - Business Wire |
| EpiCept to Report Second Quarter 2010 Operating and Financial Results on August 6, 2010 | August 03, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Amends Employment Agreement and Completes Severance Agreements with Executive Officers | July 28, 2010 | BioSpace - Breaking News |
| EpiCept Amends Employment Agreement and Completes Severance Agreements with Executive Officers | July 28, 2010 | Pharma News - Business Wire |
| EpiCept Increases Exercise Price of Warrants in June 2010 Offering | July 15, 2010 | Pharma News - Business Wire |
| EpiCept Corporation (EPCT) Names Rita Kelley Senior Director of Marketing | July 07, 2010 | Biotechnology - Moreover |
| EpiCept Corporation Names Rita Kelley Senior Director of Marketing | July 06, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Files New Drug Application for Ceplene in AML | June 29, 2010 | BioSpace - Breaking News |
| EpiCept Files New Drug Application for Ceplene in AML | June 29, 2010 | FDA News - Business Wire |
| EpiCept to Present at the OneMedForum New York 2010 | June 28, 2010 | Pharma News - Business Wire |
| EpiCept Announces Pricing of Public Offering | June 28, 2010 | FDA News - Business Wire |
| EpiCept Corporation Amends Chief Executive Officer’s Employment Agreement | June 16, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Added to Preliminary List of Companies in Russell Microcap Index | June 15, 2010 | FDA News - Business Wire |
| Epicept Corporation Reports Results of Annual Meeting of Stockholders | June 09, 2010 | Pharma News - Business Wire |
| EpiCept Announces Fulfillment of Ceplene’s Third European Post-Approval Commitment | June 01, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Announces Webcast of Annual Shareholder Meeting | May 28, 2010 | BioSpace - Breaking News |
| EpiCept Announces Webcast of Annual Shareholder Meeting | May 28, 2010 | FDA News - Business Wire |
| Targeted Patient Enrollment Reached in Phase IIb Clinical Trial for EpiCept Corporation's NP-1 in Chemotherapy-Induced Peripheral Neuropathy | May 26, 2010 | BioSpace - Breaking News |
| EpiCept Corporation Announces Commercial Launch of Ceplene® in Germany | May 21, 2010 | Pharma News - Business Wire |
| EpiCept to Present at the Rodman & Renshaw Annual Global Investment Conference | May 13, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Reports First Quarter 2010 Operating and Financial Results | May 06, 2010 | FDA News - Business Wire |
| EpiCept Earns $2 Million Milestone Payment from Meda AB | May 04, 2010 | Pharma News - Business Wire |
| EpiCept to Report First Quarter 2010 Operating and Financial Results on May 6, 2010 | May 04, 2010 | Pharma News - Business Wire |
| EpiCept Corporation (EPCT) to Present at the Biotechnology Industry Organization (BIO) International Convention | May 01, 2010 | Biotechnology - Moreover |
| EpiCept Corporation to Present at the Biotechnology Industry Organization (BIO) International Convention | April 30, 2010 | BioSpace - Breaking News |
| EpiCept to Present at the BIO International Convention | April 30, 2010 | Pharma News - Business Wire |
| Notice of the Annual Meeting of Stockholders of EpiCept Corporation | April 23, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Announces Commercial Launch of Ceplene(R) in the United Kingdom | April 19, 2010 | BioSpace - Breaking News |
| EpiCept to Present at 30th Annual Cowen and Company Health Care Conference | March 02, 2010 | Pharma News - Business Wire |
| EpiCept Reports Fourth Quarter Financial Results, Provides Business Update | February 25, 2010 | FDA News - Business Wire |
| EpiCept Adopts Amendment to Company By-Laws | February 23, 2010 | Pharma News - Business Wire |
| EpiCept to Report Fourth Quarter and Full Year 2009 Operating and Financial Results on February 25, 2010 | February 22, 2010 | Pharma News - Business Wire |
| EpiCept Corp announces at-the-market programme to sell shares for up to USD15m | February 08, 2010 | Pharmaceutical - Moreover |
| EpiCept Establishes At-the-Market Public Stock Offering Program | February 05, 2010 | Pharma News - Business Wire |
| EpiCept Corporation Regains Nasdaq Compliance | February 03, 2010 | BioSpace - Breaking News |
| EpiCept Regains Nasdaq Compliance | February 03, 2010 | Pharma News - Business Wire |
| EpiCept to Present at 12th Annual BIO CEO & Investor Conference | February 02, 2010 | FDA News - Business Wire |
| EpiCept Corporation Pain Drug Gets Special FDA Designation | January 27, 2010 | BioSpace |
| EpiCept pain drug gets special FDA designation | January 27, 2010 | Health News - CNBC |
| EpiCept Receives Orphan Drug Designation for EpiCept™ NP-1 in U.S. | January 27, 2010 | FDA News - Business Wire |
| EpiCept Corp reports Ceplene included in Swedish AML medical guidelines | January 26, 2010 | Pharmaceutical - Moreover |
| EpiCept Announces Ceplene® Included in Swedish AML Medical Guidelines | January 26, 2010 | FDA News - Business Wire |
| EpiCept Corporation Announces Reverse Split of Common Stock | January 15, 2010 | BioSpace - Breaking News |
| EpiCept Announces Executive Departure | January 14, 2010 | Pharma News - Business Wire |
| EpiCept Announces Reverse Split of Common Stock | January 14, 2010 | Pharma News - Business Wire |
| EpiCept Announces Results of Special Meeting of Stockholders | January 08, 2010 | Pharma News - Business Wire |
| EpiCept to Present at OneMedPlace Finance Forum | January 07, 2010 | Pharma News - Business Wire |
| EpiCept Provides Clinical and Business Update on Ceplene Program | | Pharma News - Business Wire |
